Air pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis

BMC Pulmonary Medicine

Volumn 17, Issue 1, 2017, Pages

  Psoter, Kevin J ^a   De Roos, Anneclaire J ^b   Wakefield, Jon ^c   Mayer, Jonathan D ^c   Rosenfeld, Margaret ^d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DREXEL UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Achromobacter xylosoxidans; Air pollution; Cystic fibrosis; Fine particulate matter; MRSA; Staphylococcus aureus; Stenotrophomonas maltophilia

Indexed keywords

ACHROMOBACTER XYLOSOXIDANS; AIR POLLUTION; ARTICLE; BIRTH; CHILD; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CYSTIC FIBROSIS; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; PARTICULATE MATTER; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK FACTOR; STENOTROPHOMONAS MALTOPHILIA; UNITED STATES; ACHROMOBACTER DENITRIFICANS; GRAM NEGATIVE INFECTION; HETEROZYGOTE; INFANT; MICROBIOLOGY; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS INFECTION; STATISTICS AND NUMERICAL DATA;

ACHROMOBACTER DENITRIFICANS; AIR POLLUTION; CARRIER STATE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYSTIC FIBROSIS; ENVIRONMENTAL EXPOSURE; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFANT; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MULTIVARIATE ANALYSIS; PARTICULATE MATTER; REGRESSION ANALYSIS; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STENOTROPHOMONAS MALTOPHILIA; UNITED STATES;

EID: 85026355486     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/s12890-017-0449-8     Document Type: Article

References (35)

1. Long FR, Williams RS, Adler BH, Castile RG. Comparison of quiet breathing and controlled ventilation in the high-resolution CT assessment of airway disease in infants with cystic fibrosis. Pediatr Radiol. 2005;35:1075-80.
2. Long FR, Williams RS, Castile RG. Structural airway abnormalities in infants and young children with cystic fibrosis. J Pediatr. 2004;144:154-61.
3. Martinez TM, Llapur CJ, Williams TH, Coates C, Gunderman R, Cohen MD, et al. High-resolution computed tomography imaging of airway disease in infants with cystic fibrosis. Am J Respir Crit Care Med. 2005;172:1133-8.
4. Hoo AF, Thia LP, Nguyen TT, Bush A, Chudleigh J, Lum S, et al. Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening. Thorax. 2012;67:874-81.
5. Mott LS, Park J, Murray CP, Gangell CL, de Klerk NH, Robinson PJ, et al. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax. 2012;67:509-16.
6. Goeminne PC, Kicinski M, Vermeulen F, Fierens F, De Boeck K, Nemery B, et al. Impact of air pollution on cystic fibrosis pulmonary exacerbations: a case-crossover analysis. Chest. 2013;143:946-54.
7. Farhat SC, Almeida MB, Silva-Filho LV, Farhat J, Rodrigues JC, Braga AL. Ozone is associated with an increased risk of respiratory exacerbations in patients with cystic fibrosis. Chest. 2013;144:1186-92.
8. Goss CH, Newsom SA, Schildcrout JS, Sheppard L, Kaufman JD. Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis. Am J Respir Crit Care Med. 2004;169:816-21.
9. Collaco JM, McGready J, Green DM, Naughton KM, Watson CP, Shields T, et al. Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study. PLoS One. 2011;6:e27784.
10. Psoter KJ, De Roos AJ, Mayer JD, Kaufman JD, Wakefield J, Rosenfeld M. Fine particulate matter exposure and initial Pseudomonas Aeruginosa acquisition in cystic fibrosis. Ann Am Thorac Soc. 2015;12:385-91.
11. Knapp EA, Fink AK, Goss CH, Sewall A, Ostrenga J, Dowd C, et al. The Cystic Fibrosis Foundation patient registry. Design and methods of a National Observational Disease Registry. Ann Am Thorac Soc. 2016;13:1173-9.
12. Cystic Fibrosis Foundation, Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, et al. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr. 2009;155:S73-93.
13. Psoter KJ, Rosenfeld M, De Roos AJ, Mayer JD, Wakefield J. Differential geographical risk of initial Pseudomonas Aeruginosa acquisition in young US children with cystic fibrosis. Am J Epidemiol. 2014;179:1503-13.
14. WWAeMI Rural Health Research Center. http://depts.washington.edu/uwruca/ruca-data.php. Accessed 14 May 2017.
15. R Development Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2017. p. 16.
16. Goss CH, Muhlebach MS. Review: Staphylococcus Aureus and MRSA in cystic fibrosis. J Cyst Fibros. 2011;10:298-306.
17. Dasenbrook EC, Checkley W, Merlo CA, Konstan MW, Lechtzin N, Boyle MP. Association between respiratory tract methicillin-resistant Staphylococcus Aureus and survival in cystic fibrosis. JAMA. 2010;303:2386-92.
18. Dasenbrook EC, Merlo CA, Diener-West M, Lechtzin N, Boyle MP. Persistent methicillin-resistant Staphylococcus Aureus and rate of FEV1 decline in cystic fibrosis. Am J Respir Crit Care Med. 2008;178:814-21.
19. Cystic Fibrosis Foundation. Patient registry 2008 annual report. Bethesda: Cystic Fibrosis Foundation; 2009.
20. Muhlebach MS, Heltshe SL, Popowitch EB, Miller MB, Thompson V, Kloster M, et al. Multicenter observational study on factors and outcomes associated with various Methicillin-resistant Staphylococcus Aureus types in children with cystic fibrosis. Ann Am Thorac Soc. 2015;12:864-71.
21. Collaco JM, Raraigh KS, Appel LJ, Cutting GR. Respiratory pathogens mediate the association between lung function and temperature in cystic fibrosis. J Cyst Fibros. 2016;15:794-801.
22. Kamdar O, Le W, Zhang J, Ghio AJ, Rosen GD, Upadhyay D. Air pollution induces enhanced mitochondrial oxidative stress in cystic fibrosis airway epithelium. FEBS Lett. 2008;582:3601-6.
23. Geiser M, Stoeger T, Casaulta M, Chen SZ, Semmler-Behnke M, Bolle I, et al. Biokinetics of nanoparticles and susceptibility to particulate exposure in a murine model of cystic fibrosis. Particle and Fibre Toxicology. 2014;11:19.
24. Qu F, Qin XQ, Cui YR, Xiang Y, Tan YR, Liu HJ, et al. Ozone stress down-regulates the expression of cystic fibrosis transmembrane conductance regulator in human bronchial epithelial cells. Chem Biol Interact. 2009;179:219-26.
25. Jassal MS, Yu AM, Bhatia R, Keens TG, Davidson Ward SL. Effect of residential proximity to major roadways on cystic fibrosis exacerbations. Int J Environ Health Res. 2013;23:119-31.
26. Dadvand P, Parker J, Bell ML, Bonzini M, Brauer M, Darrow LA, et al. Maternal exposure to particulate air pollution and term birth weight: a multi-country evaluation of effect and heterogeneity. Environ Health Perspect. 2013;121:267-373.
27. Stieb DM, Chen L, Eshoul M, Judek S. Ambient air pollution, birth weight and preterm birth: a systematic review and meta-analysis. Environ Res. 2012;117:100-11.
28. Kwinta P, Pietrzyk JJ. Preterm birth and respiratory disease in later life. Expert Rev Respir Med. 2010;4:593-604.
29. Pino P, Walter T, Oyarzun M, Villegas R, Romieu I. Fine particulate matter and wheezing illnesses in the first year of life. Epidemiology. 2004;15:702-8.
30. Karr CJ, Demers PA, Koehoorn MW, Lencar CC, Tamburic L, Brauer M. Influence of ambient air pollutant sources on clinical encounters for infant bronchiolitis. Am J Respir Crit Care Med. 2009;180:995-1001. 17
31. Collaco JM, Blackman SM, McGready J, Naughton KM, Cutting GR. Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function. J Pediatr. 2010;157:802-7.
32. Green DM, Collaco JM, McDougal KE, Naughton KM, Blackman SM, Cutting GR. Heritability of respiratory infection with Pseudomonas Aeruginosa in cystic fibrosis. J Pediatr. 2012;161:290-5.
33. Ramsay KA, Stockwell RE, Bell SC, Kidd TJ. Infection in cystic fibrosis: impact of the environment and climate. Ex Rev Resp Med. 2016;10:505-19.
34. Psoter KJ, De Roos AJ, Wakefield J, Mayer J, Rosenfeld M. Season is associated with Pseudomonas Aeruginosa acquisition in young children with cystic fibrosis. Clin Microbiol Infect. 2013;19:E483-9.
35. Rosenfeld M, Emerson J, Accurso F, Armstrong D, Castile R, Grimwood K, et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol. 1999;28:321-8.